Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SW033291 is a noncompetitive inhibitor of 15-PGDH (apparent Ki = ~0.1 nM).1 Intraperitoneal administration of SW033291 (10 mg/kg) increases the levels of prostaglandin E2 (PGE2) by two-fold in bone marrow, colon, lung, and liver in mice and, at 5 mg/kg, promotes hematopoietic recovery in a mouse model of bone marrow transplant. It reduces ulcer numbers and size and increases colonic crypt cell proliferation in a mouse model of colitis induced by dextran sulfate sodium (DSS; Item No. 23250). Systemic administration of SW033291 (5 mg/kg) induces articular cartilage regeneration in aged mice.2 Intra-articular administration of SW033291 also induces articular cartilage regeneration, as well as improves mobility and reduces pain in a catwalk gait analysis, in young mice in a model of post-traumatic osteoarthritis.
WARNING This product is not for human or veterinary use.
1. Inhibition of the prostaglandin-
2. Inhibition of 15-